Market Research Blog – Page 1160 – New Product Development

Global Central Venous Catheter Market Set to Surpass USD 5,314.5 million by 2033, Driven by Technological Advancements in “Smart” Catheters

The global central venous catheter market is poised for significant growth, with its valuation expected to exceed USD 5,314.5 million by 2033, rising from USD 3,238.1 million in 2023. This expansion represents a 5.1% compound annual growth rate (CAGR) during the forecast period, underscoring the increasing demand for innovative and life-saving medical devices.

One of the key drivers of this market’s growth is the emergence of “smart” central venous catheters, which integrate modern technology with traditional vascular access tools. Equipped with sensors, microprocessors, and real-time communication capabilities, these advanced devices monitor both catheter function and patient status, greatly enhancing safety. By identifying potential issues such as malpositioning or catheter occlusion, smart catheters help to prevent complications like catheter-related bloodstream infections (CRBSIs), a major cause of hospital-acquired infections. As patient safety and infection prevention become top priorities in healthcare settings, the demand for these cutting-edge devices is surging.

Additionally, the rising awareness of parenteral nutrition therapy is propelling the need for central venous catheters. Parenteral nutrition, the intravenous delivery of essential nutrients, is critical for patients unable to receive adequate nutrition through oral or enteral means. This therapy is commonly used for individuals with severe gastrointestinal conditions, cancer patients undergoing treatment, and post-surgery patients. The growing emphasis on proper nutrition for recovery and overall health is further driving the adoption of central venous catheters in hospitals and healthcare settings.

Key Insights from the Central Venous Catheter Market Report:

The market was valued at USD 2,446.9 million in 2018, with a growth of 4.7% CAGR from 2018 to 2022.
In 2022, the market size reached USD 3,074.7 million.
The non-anti-microbial catheter segment accounted for 75.7% of market shares in 2022.
The double lumen segment dominated with a 63.6% market share in 2022.
Hospitals emerged as a key end-user segment, holding 60.3% of the market in 2022.
The United Kingdom’s market is set to develop at a robust 9.0% CAGR through 2033.
Germany is projected to grow at a 3.3% CAGR, while Australia’s market is expected to thrive at 5.1% CAGR through 2033.

As the central venous catheter industry continues to innovate and meet the growing demands of patient care, it is well-positioned to expand further, offering improved patient outcomes and reducing the risks of complications.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Recent Developments Observed by FMI:

Coloplast unveiled a novel catheter in the United States in January 2023. The SpeediCath Flex Set catheter is intended for use by those with bladders and urine problems. Triple Action Coating Technology is a feature on all SpeediCath catheters designed to reduce the risk of urethral damage and urinary tract infections (UTIs) for patients with spinal cord injuries (SCI).
Braun Medical Inc. (B. Braun), a pioneer in infusion therapy, announced the launch of its new Introcan Safety 2 IV Catheter with one-time blood control in July 2022. The Introcan Safety 2 IV Catheter, the newest invention from B. Braun, makes IV access safer for the clinician by reducing the risk of blood exposure and needlestick accidents.

Key Players in the Central Venous Catheter Market:

Angio Dynamics
C.R. Bard
Teleflex Incorporated
B. Braun Melsungen AG
Kimal Healthcare
Come B.V.
Medtronic Plc
Smiths Medical
Vygon (UK) Ltd.
Becton, Dickinson, and Company
Argon Medical Devices Inc.
Boston Scientific Corporation
Cook Medical Incorporated
Medical Components Inc.
Fresenius Kabi AG

Central Venous Catheter Market Segmentation:

By Product:

Dialysis Catheters
Acute Hemodialysis Catheter
Chronic Hemodialysis Catheter
Peritoneal Dialysis Catheter
PICC Catheters
Implantable Port
CVC Catheters
Tunneled Catheters
Non-tunneled Catheters

By Property:

Anti-microbial Catheter
Non-Anti-Microbial Catheter

By Design:

Single Lumen
Double Lumen
Multiple Lumen

By End-user:

Hospitals
Ambulatory Surgical Centers
Dialysis Centers
Specialty Clinics
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Dermatology Devices Market Poised for Remarkable Growth, Set to Exceed USD 9,803.0 Million by 2033

The global dermatology devices market is on a significant upward trajectory, with market forecasts predicting a substantial surge in growth over the next decade. According to the latest market analysis, the sector, valued at USD 5,213.0 million in 2023, is projected to exceed USD 9,803.0 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.

Several key factors are driving this growth:

Increased Prevalence of Skin Disorders: The rising incidence of skin-related health issues such as acne, eczema, and skin cancer is fueling the demand for advanced dermatology devices to ensure effective and efficient treatments.
Growing Awareness of Skin Health: As public awareness of skin health and wellness increases, more people are investing in skincare, driving the adoption of dermatology devices for both medical and cosmetic purposes.
Advancements in Treatment Technologies: Revolutionary advancements in laser technology, cryotherapy, and light therapy are reshaping the dermatology treatment landscape. These innovations are not only enhancing the effectiveness of dermatological solutions but also making treatments more accessible to a wider range of patients.
Aging Population: The increasing elderly population is contributing to the demand for dermatological treatments, particularly those related to age-related skin conditions and the desire for cosmetic enhancements.
Rising Disposable Incomes: With more disposable income, individuals are increasingly opting for cosmetic procedures and dermatological treatments, further boosting the market.
Emphasis on Aesthetic Appeal: The growing societal emphasis on aesthetics and personal appearance is propelling demand for cosmetic dermatology devices aimed at enhancing skin tone, texture, and overall appearance.
Expansion of Teledermatology and AI Integration: The integration of teledermatology and AI-driven diagnostic tools is revolutionizing dermatological care, offering patients more accurate, efficient, and convenient solutions.

Industry experts predict that ongoing technological advancements will continue to shape the future of the dermatology devices market. Companies are urged to invest in cutting-edge product development and pursue strategic partnerships to remain competitive and meet the evolving needs of consumers.

As the dermatology devices market flourishes, both industry stakeholders and consumers stand to benefit from the innovations and solutions that are transforming dermatological health. The remarkable growth projections highlight the increasing importance of dermatology in health and wellness and emphasize the pivotal role technology will play in the future of skincare treatments.

Unveil the Dermatology Devices Surge: Read Our Detailed Report for Essential Trends and Insights!

Key Takeaways from the Dermatology Devices Industry:

The laser segment in the dermatology devices market commands a significant 46.1% market share in 2023.
The skin rejuvenation application segment captures a substantial 21.6% market share in 2023 in the global dermatology devices industry.
Specialty dermatology clinics are the preferred choice for dermatological procedures in the dermatology devices market, holding a significant 38.9% market share in 2023.
In the United States, the laser segment dominates the dermatology devices market with a remarkable 46.1% market share in 2023, fueled by a growing aging population and widespread adoption of advanced laser technologies.
Germany’s dermatology devices market, representing 2.9% of the global market share in 2023, is characterized by precision and quality, with German manufacturers renowned for their innovative laser and cryosurgery devices.
Japan’s dermatology devices market, accounting for 3.7% of the global market share in 2023, is propelled by advancements in aesthetic dermatology, catering to an increasingly skin-conscious population.
Australia captures a 3.7% market share in the global dermatology devices market in 2023, driven by rising skin health awareness and a preference for home-use devices among its skincare-conscious populace.
China’s dermatology devices market boasts a significant 7.2% market share in 2023, primarily due to the rapid expansion of the aesthetic industry and strategic collaborations between manufacturers.
India’s dermatology devices market secures a substantial 5.8% market share in 2023, powered by the surge in cosmetic dermatology procedures and the availability of affordable dermatology devices.
The United Kingdom’s dermatology devices market leads with a 7.4% market share in 2023, largely driven by the thriving aesthetic clinics industry and the popularity of minimally invasive dermatological procedures.

Key Players Striving to Obtain Greater Share in the Dermatology Devices Industry:

The competitive landscape of the dermatology devices industry is marked by a dynamic interplay of established market leaders, innovative startups, and evolving technological trends. Market giants like Lumenis Ltd., Cynosure (a division of Hologic, Inc.), and Alma Lasers hold sway with their extensive product portfolios and global reach. In contrast, nimble startups such as Cutera Inc., Sciton Inc., and Syneron Candela inject innovation into the market, often disrupting traditional treatment methods with novel technologies.

Continuous technological advancements remain a driving force in the industry, with companies heavily investing in research and development. Innovations such as AI integration, smart devices, and portable equipment are reshaping the dermatology devices landscape. Global expansion efforts target emerging markets like China and India, capitalizing on the rising disposable income and growing skincare awareness.

Strategic collaborations between dermatology device manufacturers and healthcare institutions, coupled with product diversification spanning laser therapy, cryosurgery, and microdermabrasion, underscore the multifaceted competitive dynamics. Mergers and acquisitions are common, reshaping the market landscape as companies seek to expand their portfolios. Balancing cost competitiveness without compromising quality remains a central challenge, as consumers increasingly seek value-driven solutions.

Recent Developments in the Dermatology Devices Market:

Cynosure released their new PicoSure Pro gadget, the newest improvement to the PicoSure platform.
Cutera debuted its new Excel V laser, which is intended to be more successful and less uncomfortable for patients.
On June 15, 2023, Hologic unveiled their new SculpSure Body gadget, a non-invasive body shaping technology that employs radiofrequency radiation.
On June 8, 2023, Lumenis introduced their new UltraPulse Encore laser, which is intended to be more adaptable and effective for a wider range of skin treatments.
Alma Lasers introduced their new Harmony XL Pro device, a modular platform that can be utilized for various cosmetic treatments such as laser hair removal, tattoo removal, and skin resurfacing.

Key Companies in the Market:

Alma Lasers GmbH
Cynosure, Inc.
Solta Medical, Inc.
Cutera, Inc.
Syneron Medical Ltd.
Canfield Scientific, Inc.
3Gen
Aesthetic Group
Ambicare Health
Image Derm, Inc.
Lumenis, Ltd.
Bausch Health Companies Inc
Bruker Corporation
Carl Zeiss
Genesis Biosystems, Inc.
Heine Optotechnik GmbH & Co. Kg
Michelson Diagnostics, Ltd.
Photomedex, Inc.

Key Market Segments Covered In Dermatology Devices Industry Research:

By Product Type:

Lasers
Fractional
Diode
InfraRed 1319 nm
Alexandrite laser
Nd: YAG 1064 nm
Pulsed
Potassium Titanyl Phosphate (KTP)
IPL devices
RF Devices
Microdermabrasion Devices
Others

By application:

Vascular Lesions
Telangiectasia
Hemangiomas
Port wine stains
Venous lakes
Scar Removal
Red or hypertrophic scars
Hyperpigmentation
Tattoo removal
Hair removal
Wrinkle Removal
Acne Treatment
Skin Rejuvenation
Pore Reduction
Others

By End User:

Hospitals
Specialty Dermatology Clinics
Private Clinics

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

About Future Market Insights (FMI)

Contact Us:

Global Ophthalmic Lasers Market to Reach USD 1.3 Billion by 2030 Amid Rising Demand for Advanced Eye Care Solutions

The global ophthalmic lasers market is experiencing a strong growth trajectory, projected to expand from USD 884.3 million in 2022 to an impressive USD 1.3 billion by 2030. With a Compound Annual Growth Rate (CAGR) of 5.4%, this significant growth is being driven by an increasing prevalence of eye diseases worldwide and a growing demand for innovative ophthalmic laser devices.

As eye health becomes an ever-more critical concern, heightened awareness and greater consumer spending on advanced eye care are playing key roles in the market’s expansion. A growing preference for minimally invasive laser treatments and rapid developments in eye infection treatments are also fueling demand for ophthalmic laser machines.

Rising Demand for Effective Eye Care Solutions:

Eye diseases such as glaucoma, cataracts, and diabetic retinopathy are on the rise globally, increasing the need for advanced laser treatments. The market is responding with state-of-the-art solutions that address these conditions effectively, offering healthcare providers and patients improved treatment options.

“The market’s steady growth underscores the increasing need for advanced and effective eye care solutions,” said FMI in a recent statement. “Our focus remains on innovating and providing cutting-edge ophthalmic laser technology to meet the evolving needs of both healthcare providers and patients.”

Key Market Drivers:

Rising Prevalence of Eye Diseases: The global surge in conditions such as glaucoma and cataracts has created a growing demand for laser-based treatments.
Increased Consumer Awareness and Spending: Consumers are becoming more informed about the importance of eye health and are willing to invest in advanced treatments.
Preference for Minimally Invasive Treatments: Patients increasingly opt for minimally invasive laser treatments due to their reduced recovery times and improved outcomes.

The future of the ophthalmic lasers market is bright, with ongoing technological advancements and increased adoption of laser treatments expected to drive continued growth in the coming years.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!

Key Takeaways: Ophthalmic Lasers Market Growth

The global ophthalmic lasers market is expected to reach USD 1.3 billion by 2030, driven by a moderate CAGR of 5.4%.
Increasing prevalence of eye diseases like cataracts, especially in the aging population, is boosting demand for ophthalmic lasers.
The US leads the market due to high incidence of eye conditions, advanced technology, and favorable government support for laser surgery.
Germany’s market is growing due to a preference for painless laser procedures and strong presence of leading manufacturers.
China’s market is expected to see significant growth due to its rapidly aging population, rising awareness of laser treatments, and flourishing medical tourism.
The report identifies key investment opportunities in the market, catering to hospitals and ophthalmology clinics.
The study analyzes factors driving growth in Asia Pacific and explores the interrelation between ophthalmic lasers and laser therapy devices. Additionally, it examines strategies adopted by leading manufacturers.

Key companies profiled:

Abbott Medical Optics, Inc., Alcon Inc. (Novartis AG), Bausch & Lomb Incorporated, LENSAR, LLC, NIDEK CO., LTD, iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, and SCHWIND eye-tech-solutions GmbH & Co. KG.

Ophthalmic Lasers Market by Category:

By Product:

Excimer Lasers
Femtosecond Laser

By Application:

Refractive Surgery
Cataract Surgery
Posterior Capsulotomy
Trabeculoplasty
Diagnostic

By End User:

Hospital
- 500 Bedded+
- 250-499 Bedded
- Less than 250
Ambulatory Surgical Centers
Ophthalmology Clinics

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Japan
South Korea
China
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Global Positron Emission Tomography (PET) Scanners Market Poised for Significant Growth: Projected to Reach USD 2.1 Billion by 2033

The global positron emission tomography (PET) scanners market is on track for remarkable growth, with projections indicating a rise in market value from USD 1.3 billion in 2023 to USD 2.1 billion by 2033. This anticipated growth, with a Compound Annual Growth Rate (CAGR) of 5.3% over the next decade, underscores the increasing demand and technological advancements within the healthcare sector.

The primary driver behind this market expansion is ongoing innovation in medical imaging technology. Recent advancements in PET scanners have greatly enhanced their ability to detect and diagnose diseases in the early stages. This has led to widespread adoption of PET scanners across healthcare facilities globally, setting new benchmarks in diagnostic precision and improving patient care.

Key Growth Factors:

Technological Innovations: A significant factor in market growth is the integration of PET with X-ray transmission computed tomography (CT) scans. This combination reduces acquisition time, improves disease staging, and enhances diagnostic sensitivity and specificity. The fusion of PET and CT scans provides detailed imaging that helps healthcare professionals make more informed decisions about patient care.
Advanced Radiotracers: Most PET scanners currently utilize fluorodeoxyglucose (FDG) to capture tissue glucose metabolism. However, ongoing research into new radiotracers is addressing unmet clinical needs, with new products offering greater sensitivity for metabolic activity, enabling more precise and detailed scans.
Regulatory and Reimbursement Landscape: The market is also shaped by regulatory requirements, mandatory equipment registrations, and changes in reimbursement policies. Additionally, advances in minimally invasive procedures and the introduction of new patented products are further driving growth in the PET scanner market.
Impact of COVID-19: While the COVID-19 pandemic initially reduced the demand for elective surgeries and led to an increase in telehealth services, the adoption of digital PET scanners has surged. These digital scanners provide superior image quality, contributing to the market’s robust growth despite the challenges posed by the pandemic.

PET scanners have become a critical tool in modern medicine, offering detailed insights into physiological processes and enabling early detection of conditions such as cancer, cardiovascular diseases, and neurological disorders. As the market continues to evolve, the focus on technological advancements and expanding applications is expected to further propel its growth, ensuring that PET scanners remain at the forefront of diagnostic innovation.

With a promising decade ahead, the global PET scanners market is set to experience substantial growth, driven by technological innovations, new radiotracers, and evolving regulatory frameworks. These advancements are not only enhancing diagnostic accuracy but also improving patient outcomes by enabling earlier and more targeted treatments.

Positron Emission Tomography Scanners in Demand: Check Out Our Full Report for a Complete Overview of the Trends and Insights!

Competitive Landscape:

Leading companies in the PET scanners market are focusing on innovative approaches to meet the growing demand for efficient disease detection methods. Key players such as G.E. Healthcare, Toshiba Corporation, Koninklijke Philips N.V., Siemens Healthineers, and others are expanding production facilities, launching new products, and obtaining approvals to strengthen their market positions.

Regional Insights:

The U.S. is anticipated to dominate the North American market, accounting for approximately 94.4% of the total market share in 2020. The rising prevalence of cancer in the country has created a strong demand for advanced PET scanners, offering significant sales prospects in the market.

Industry Segmentation:

The PET scanners market is categorized by product type, application, detector type, and end-user:

By Product Type: Full-ring PET Scanner, Partial-ring PET Scanner
By Application: Oncology, Cardiology, Neurology, Others
By Detector Type: Bismuth Germanium Oxide, Lutetium Oxyorthosilicate, Gadolinium Oxyorthosilicate, Lutetium Fine Silicate, Lutetium Yttrium Orthosilicate
By End User: Hospitals, Diagnostic Centers, PET Centers, Research Institutes

About Future Market Insights (FMI)

Contact Us:

Global Intraosseous Infusion Devices Market Set for Explosive Growth, Projected to Reach USD 8.6 Billion by 2033

The global market for intraosseous infusion devices is on a remarkable upward trajectory, with market valuation expected to surge from USD 4.4 billion in 2023 to a staggering USD 8.6 billion by 2033. This robust growth is forecasted to be driven by an impressive Compound Annual Growth Rate (CAGR) of 6.9%, signaling a substantial increase in the adoption of these critical devices across the world.

Intraosseous infusion devices are becoming increasingly vital in the global healthcare landscape, particularly in emergency medical scenarios. Recent market analysis reveals that demand for these devices is fueled by advancements in healthcare technologies and a growing emphasis on emergency medical care. The rising need for rapid, effective vascular access in life-threatening situations has underscored the value of intraosseous infusion devices in delivering quick and reliable methods of administering fluids and medications, especially when traditional intravenous access proves difficult or time-consuming.

“Intraosseous infusion devices are transforming the way we approach emergency care. These devices play a crucial role in trauma, cardiac arrest, and severe dehydration cases where immediate vascular access can mean the difference between life and death,” said a leading industry expert. “As the frequency of such medical emergencies grows and healthcare systems worldwide focus on improving emergency response, the demand for intraosseous infusion solutions is expected to continue its upward trajectory.”

Key to the market’s expansion is the increasing use of intraosseous infusion devices in critical medical situations. With healthcare infrastructures improving globally and technology advancing rapidly, intraosseous infusion devices are being integrated into emergency protocols, ensuring enhanced patient outcomes and streamlined medical responses.

The growth potential of this market has not gone unnoticed by stakeholders, who are ramping up investments in research and development. Continuous innovation in intraosseous infusion technology is expected to unlock new opportunities for growth, further solidifying the critical role of these devices in modern healthcare.

As the market for intraosseous infusion devices continues to evolve, it is clear that these solutions will remain indispensable in the quest to provide efficient, life-saving care in emergency settings.

Key Takeaways from Intraosseous Infusion Devices Market Study:

By product, EZ-IO holds the maximum share of 20% in the market in 2021, expanding at 6.4% CAGR during the forecast period.
By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
By technology, the automatic segment will account for more than 50.8% of the market share in 2021.
By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.

“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst

Who is winning?

Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.

Cook Medical: Every medical profession we offer has two common threads: patients who want to be healthy and clinicians who desire more user-friendly tools. As a result, we devote significant resources to designing, manufacturing, and delivering a differentiated range of minimally invasive medical devices to healthcare systems worldwide.
Becton Dickinson and Company: With a product line that fulfils the needs of patients, we want to increase physician satisfaction while also assisting hospitals and surgery centres in improving results and lowering expenses. BD has refined surgical instruments and led to improved results for more than a century. with a substantial portfolio and a track record of supplying high-quality items

The key market players covered by FMI include:

Pyng Medical Corp.
Biopsybell
Cook Medical Incorporated
PAVmed
PerSys Medical
Aero Healthcare
Teleflex, Inc.
Becton Dickinson and Company
SAM Medical
Cardinal Health, Inc

Intraosseous Infusion Devices – Market by Category:

Product:

B.I.G
FAST1
EZ-IO
FASTR
IO Needles
Others

By Route of Administration:

Sternum
Distal & Proximal Tibia
Distal Femur
Calcaneus
Head of Humerus

By Technology:

Manual
Automatic
- Impact Driven
- Power Drill

About Future Market Insights (FMI)

Contact Us:

GCC Medical Glove Industry Expected to Reach USD 213.7 Million by 2034, Driven by Rising Healthcare Demand and Medical Tourism

The GCC medical glove industry value in 2019 was USD 152.1 million and it witnessed a year-on-year growth rate of 1.9% in the following five years. The medical glove industry in GCC is estimated to be valued at around USD 170.3 million in 2024.

As per the new findings, medical disposable glove sales in GCC are projected to increase at 2.3% CAGR through 2034. Further analysis of the industry reveals the GCC medical glove industry value is expected to reach USD 213.7 million by 2034.

The significance of medical disposable gloves in preventing infections was highlighted during the pandemic years resulting in stockpiling and their higher usage in the Gulf countries. Further, the rising demand for disposable medical gloves in the Gulf Cooperation Council countries can be attributed to increased healthcare spending and the higher influx of medical tourists.

Key Takeaways from the GCC Medical Glove Industry Study Report:

The regional industry is expected to witness absolute growth opportunity of USD 43 million over the next ten years.
The Kingdom of Saudi Arabia (KSA) is expected to remain a key region for medical gloves by expanding at a rate of 3.8% per year till 2034.
Demand for medical gloves in the UAE is expected to rise at a lucrative CAGR of 4% through the projected years.
The disposable examination gloves segment is estimated to account for 69% of the total industry share in 2024.
In terms of end users, sales of medical gloves to hospitals in GCC is expected to account for 49% of the total industry share in 2024.

Competitive Landscape for the GCC Medical Glove Industry Participants:

The medical glove industry in the Gulf Cooperation Council (GCC) is moderately competitive. However, with the advancements in material science and manufacturing techniques, a rise in local medical glove manufacturers can be witnessed these days. Meanwhile, the established players are adopting new product designs to stay competitive in the present time. For instance, the curved finger shape and contoured palm of Ansell’s Solvex® nitrile gloves provide a stable wet grip.

“The GCC nations’ governments have imposed stringent regulations and have increased investment in healthcare equipment industries to foster a safety-conscious culture. The inclusion of overseas companies is also encouraged by different national governments to assist the growth of the health industry,” – says a lead analyst at FMI

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Recent Developments by the GCC Medical Glove Industry Players:

In June 2021, Hotpack Global, the world’s largest producer of disposable food packaging goods, launched `Eco Store.’ It was the company’s first unique online retail location for eco-friendly food packaging products, including disposable gloves, in the United Arab Emirates. The firm also stated that there is a growing demand for green packaging goods globally due to increased environmental consciousness

In April 2023, Anshell Healthcare introduced its chemically Resistant Nitrile Gloves Ansell AlphaTec® 37-185. Strong and chemical resistance combine to provide an exceptional combination in the high-performance nitrile compound. These gloves provide better snag, puncture, and abrasion protection than rubber or neoprene gloves since they are latex-free and unlined. The firm claims it to be ideal for intensive cleaning tasks as the gloves won’t deteriorate, bloat, or weaken.

Key Players Profiled in the GCC Medical Glove Industry Report:

Paul Hartmann AG
Hotpack Packaging Industries LLC
Falcon (Falcon Pack)
Deeko Bahrain
Salalah Medical Supplies Mfg. Co. LLC
United Medical Industries
NAFA Enterprises Ltd.
Liberty Industries, Inc.
Ansell Healthcare
Mckesson Corporation
Cardinal Health, Inc.
Medline Industries, Inc.

Key Segments Covered by GCC Medical Glove Industry Survey Report:

By Raw Material:

Latex
Nitrile Rubber
Vinyl Rubber
Polyisoprene
Other Materials

By Product Type:

Examination
Surgical
Chemotherapy

By Form:

Powdered form Gloves
Powder-free form Gloves

By Type of Use:

Disposable Gloves
Re-usable Gloves

By End User:

Hospital Use
Clinic Use
Ambulatory Surgery Centre Use
Diagnostic Imaging Centre Use
Rehabilitation Centre Use

By Distribution Channel:

Direct Selling Channel
Medical Store Channel
E-Commerce Channel
Other (Retail Store or Hypermarket) Channel

By Countries:

Kingdom of Saudi Arabia (KSA)
United Arab Emirates (UAE)
Qatar
Bahrain
Oman
Kuwait

About Future Market Insights (FMI)

Contact Us:

Global Colostrum Market to Reach USD 6.9 Billion by 2034, Driven by Demand for Convenient Chewable Tablets

According to the latest analysis, the global colostrum market value is expected to be valued at US$ 3,179.5 million in 2024 and is set to reach US$ 6,923.5 million by 2034. Over the next decade, global colostrum demand will likely increase at a healthy CAGR of 8.1%.

Colostrum chewable tablets are expected to remain highly sought-after colostrum supplements. This is due to their multiple advantages, including convenience and palatability. The target segment will likely total a market valuation of US$ 1,126.3 million in 2034.

Several factors are expected to propel demand for colostrum products during the assessment period. These include:

Increasing awareness among consumers about the potential health benefits of colostrum, including its high nutritional value and immune-boosting properties
Growing interest in natural products
Expanding the application of colostrum in nutraceuticals, infant formulas, and dietary supplements
Escalating demand for functional foods

Colostrum is rich in immunoglobulins and has other immune-boosting properties. This is expected to drive its demand throughout the assessment period.

With consumers becoming more health-conscious and seeking ways to enhance their immune systems, there is a growing demand for colostrum-based products. This is a key factor expected to boost the growth of the colostrum industry.

Colostrum is widely used as an ingredient in several dietary supplements, nutraceuticals, and functional foods. Thus, increasing demand and consumption of these products will likely bolster sales of colostrum during the assessment period.

Colostrum is also gaining immense traction in the infant formula industry. It is becoming a valuable ingredient in infant formula owing to its nutritional benefits. This is another driver for the global colostrum industry.

Top manufacturers are diversifying their product offerings by developing a range of colostrum-based products, such as powders, supplements, capsules, and skincare products. This allows them to cater to different consumer preferences and needs.

The booming e-commerce is making it easy for colostrum manufacturers to expand their customer base. With online marketplaces, manufacturers are expanding their reach into new markets and tapping into the global market. This will create lucrative growth opportunities for colostrum manufacturers.

Key Takeaways from the Colostrum Report:

The global market for colostrum is expected to reach a valuation of US$ 6,923.5 million by 2034.
Global demand for colostrum will likely rise at 1% CAGRthrough 2034.
Based on product type, the chewable tablets segment is projected to account for a revenue share of 7% in 2024.
By end-use, the online retailing segment is set to grow at a CAGR of 5% through 2034.
North America is set to account for a prominent global market share of 6% by 2034.
Japan’s market is poised to exhibit a value CAGR of 6% from 2024 to 2034.

“The colostrum market continues to thrive, driven by rising consumer interest in natural immune support and sports nutrition. Manufacturers are innovating with diverse product offerings, addressing sustainability concerns, and leveraging online platforms for direct sales. Scientific research and collaborations contribute to the market’s credibility, aligning with clean labels and personalized nutrition trends,” – Nandini Roy Choudhury, Client Partner at Future Market Insights

Who is Winning?

Colostrum BioTec GmbH, Biostrum Nutritech Pvt. Ltd., Zuche Pharmaceuticals, Agati Healthcare Pvt. Good Health New Zealand, Biodane Pharma A/S, Ingredia Nutritional (Ingredia S.A.), Ltd., McePharma, Cure Nutraceuticals Pvt. Ltd., Australian by Nature, La Belle Inc., NIG Nutritionals Limited, Biotaris B.V., Sterling Technology, and Pantheryx Inc. are key colostrum manufacturers listed in the report.

Top players are constantly upgrading their portfolios by launching new colostrum products. They also use strategies like advertisements, collaborations, partnerships, mergers, acquisitions, agreements, and facility expansions to stay ahead of the competition.

For instance,

In 2021, Cogent Breeding unveiled a new Primestart colostrum product, which is a replacer for the new-born calf.
In 2022, PanTheryx introduced a supplement formulated for the healthcare practitioner channel, which provides extra immune support and digestive health supplements.

Drive Your Growth Strategy Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/897

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global colostrum market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.

The study offers compelling insights into the colostrum industry based on nature (organic and conventional), product type (whole and colostrum finished products), end-use (B2B and B2C), and animal type (cow and buffalo) across several regions

About Future Market Insights (FMI)

Contact US:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Diabetic Food Market Set to Reach USD 17.9 Billion by 2034, Driven by Rising Global Diabetes Prevalence

The global diabetic food market value is expected to rise from USD 12,000 million in 2024 to USD 17,891 million by 2034. Global demand is forecast to surge at a CAGR of 8.3% over the next decade.

Multiple factors are expected to stimulate growth of the diabetic food market during the forecast period. These include increasing prevalence of diabetes, growing health awareness, and shifting dietary preferences.

In matters of health, an unhealthy diet can pose a risk of morbidity. To manage extreme health conditions like type 2 diabetes, consumers are being advised to keep their diet in check. Since this health condition is associated with food, patients with diabetes are heavily filling their kitchen inventories with specialized diabetic food.

In the diabetic food industry, grocers and fresh food producers compete not only on prices but also on food tastes. Players are thus investing in research and development to formulate diabetic foods that taste good and look pleasing.

Governments are also doing their part by imposing taxes on high-sugar products to boost the attractiveness of healthier substitutes from a cost perspective. In addition, the wave of natural and organic diabetic foods is making an impact on the diabetic food market.

Players are seen developing plant-based diets to manage diabetes. Researchers are also developing future strategies to make diabetes management simpler and sustainable. Leading companies are also focusing on ethical and sustainable production practices to align themselves with the latest market trends.

Key Takeaways from the Diabetic Food Market Report

The diabetic food industry is projected to total USD 17,891 million by 2034.
By product type, the confectionery segment is projected to acquire a 4% share in 2024.
Based on distribution channel, the supermarkets and hypermarkets segment is anticipated to obtain a value share of 32% in 2024.
The United States is projected to account for a value share of 4% in 2024.
China is poised to register a CAGR of 2% through 2034.

“Growing prevalence of diabetes and its high mortality rate are expected to play key roles in propelling demand for diabetic foods globally during the assessment period.” – Nandini Roy Choudhury, Client Partner at Future Market Insights

Who is Winning?

Key players are innovating and expanding their diabetic-friendly food offerings. New textures, flavors, and formulations are being explored to serve the evolving tastes and dietary requirements of diabetic patients. Various manufacturers have also started using alternative sweeteners, high-fiber content, and low-glycemic ingredients to improve products’ appeal and nutritious content.

Industry participants are engaging in partnerships with other companies, research institutions, and healthcare providers to create new products. Partnerships between these entities also aim at developing educational campaigns about diabetes and expanding into new markets.

Players are further employing effective branding and marketing strategies to pull the attention of diabetic patients. Manufacturers are differentiating their products via packaging designs, branding initiatives, and targeted messaging that resonate with the target audience.

Leading Diabetic Food Brands

Unilever
Nestlé
PepsiCo
The Coca-Cola Company
Kellogg Co
Mars Incorporated
FIFTY/50 MANAGEMENT GROUP
Chapman’s
Others

Latest Industry Developments

In January 2024, Rebar launched diabetic-friendly beverages in collaboration with DMC Medical Center. The new beverage series is based on fruit sugar and has over 25% reduced carbs.
In January 2024, Shwapno, a renowned chain of retail shops in Bangladesh, inaugurated a service called ‘Diabetic Corner’ to offer more facilities for consumers and create mass awareness about diabetes.

Drive Your Growth Strategy Purchase the Report for Key Insights:

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides a thorough, detailed and unbiased analysis of the global diabetic food market, presenting historical demand data for the years 2019 to 2023 and forecast statistics for the years 2024 to 2034.

The study provides compelling industry insights based on product type (dietary beverages, dairy products, baked products, ice cream and jellies, and confectionery, among others) and distribution channel (supermarkets and hypermarkets, specialty stores, grocery stores, online stores, and others) across several regions.

About Future Market Insights (FMI)

Dietary Supplement Market to Reach USD 170.1 Billion by 2034, Driven by 9.5% CAGR and Rising Demand for Probiotics & Prebiotics

The global dietary supplement market value is poised for significant growth, with projections indicating it will attain a valuation of approximately USD 170.1 billion by 2034. This represents a steady compound annual growth rate (CAGR) of 9.5% from 2024 to 2034. The market is expected to reach USD 74.3 billion by the end of 2024, driven by several key trends and factors that are shaping the industry.

Key Trends in the Dietary Supplement Market

The increasing demand for probiotics and prebiotics aimed at enhancing digestive health is one of the leading trends in the market. Government agencies worldwide are focusing on revising food laws, which is likely to impact product claims and labels, influencing consumer choices. Additionally, the growing demand for sports nutrition supplements, particularly among bodybuilders and athletes, is driving market growth as these products help improve endurance and strength.

Market Dynamics and Growth Factors

Probiotics and Prebiotics: The rising awareness of gut health and the benefits of probiotics and prebiotics is driving demand. Consumers are increasingly seeking products that support digestive health and overall well-being.
Sports Nutrition Supplements: With a surge in the number of health-conscious individuals and athletes, there is a growing demand for supplements that enhance physical performance. Sports nutrition supplements are gaining traction for their ability to support muscle growth, endurance, and recovery.
Government and Private Sector Initiatives: Various government NGOs and private organizations are creating awareness about the nutritional benefits of vitamins and minerals, further boosting market demand. These initiatives are particularly focused on reducing nutrient deficiencies among different population segments.
Natural Health Supplements: There is an increasing preference for natural health supplements among consumers, especially sports enthusiasts. These supplements are sought after for their ability to reduce wear and tear, enhance muscular strength, and restore energy levels.

Herbal Supplement Market Insights

The use of dietary supplements among young athletes to decrease body fat, enhance muscle tone, and manage weight is projected to accelerate market growth. Multivitamin and mineral supplements are gaining traction due to the need for essential nutrients among athletes engaged in rigorous exercise. The consumption of multivitamin supplements helps safeguard health and fill nutritional gaps caused by dietary preferences, food allergies, or restrictive diets.

Innovations and Technological Advancements

The dietary supplement market is also benefiting from innovations in microencapsulation and nanoencapsulation technologies. These advancements allow manufacturers to add specialty ingredients to their products, catering to the rising demand for scientifically proven supplements. Microencapsulation technology ensures a proper supply of vitamins and minerals in one’s diet, making it possible to fortify staple food items in developing countries where affordability is a concern.

Country-wise Insights

The US dietary supplement market is expected to witness a CAGR of 6.7% through 2034. Factors such as the prioritization of holistic wellness, increasing consumer interest in supplements for overall well-being, and stringent safety standards by the FDA are driving growth.
China is projected to showcase a CAGR of 7.8% during the evaluation period, driven by government regulations, growing consumer awareness, and the rising geriatric population.
The dietary supplement market in Australia is anticipated to expand at a steady CAGR of 8.4% from 2024 to 2034, fueled by the high influx of tourists, a wellness-focused culture, and the availability of herbal supplements.

Act Now to Explore In-Depth Market Analysis: Purchase Now to Access Market Intelligence: https://www.futuremarketinsights.com/checkout/263

Competitive Landscape

Key players in the dietary supplement market are BASF SE, Abbott Laboratories, Bayer AG, Glanbia Plc, Royal DSM N.V., Now Health Group, Inc., Herbalife International, Amway Corp., ADM, Arkopharma, GlaxoSmithKline plc, and Ayanda.

Leading manufacturers are focused on developing high-quality dietary supplements, coupled with offering gluten-free products with high nutritional value. The increasing demand for value-added products in several countries is expected to create new opportunities.

Recent Dietary Supplement Market Developments

In January 2024, BioAdaptives Inc., a prominent manufacturer and supplier of innovative, all-natural dietary supplements, announced the launch of a specialized research and development Food Lab. It is dedicated to the development of natural powder products and treats for animal and human consumption.
In January 2024, Smart Protein, which is part of The Original Fit Factory’s wellness chain of products and services, announced the launch of an all-new, high-quality active wellness supplement across 142 Tesco stores in the United Kingdom.

Dietary Supplement Market Outlook by Category

By Form:

Soft Gel (Capsule)
Gummies
Powders
Liquid
Bars
Others

By Ingredients:

Vitamin
Minerals
Botanical Supplements
Amino Acid
Others

By Application:

Weight Management
Immune & Digestive Health
General Health
Heart Health
Sports Nutrition
Brain/Mental Health
Bone & Joint Health
Others

By End-user:

Children
Women
Men

By Sales Channel:

Store-based Retailing
- Hypermarkets/Supermarkets
- Conventional Stores
- Drug Stores & Pharmacies
- Other Retailers
Online Retailing

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Adjacent Markets and Opportunities

The dietary supplement market is closely linked with other sectors such as the probiotic supplement market and the digestive health supplement market. The probiotic supplement market is expected to grow at a CAGR of 13.0%, driven by the focus on gut health among millennials. The digestive health supplement market is projected to expand at a CAGR of 6% from 2024 to 2034, influenced by changing dietary patterns and the increasing prevalence of digestive issues.

As the global dietary supplement market continues to grow, it presents numerous opportunities for investors and businesses. The rising demand for innovative and high-quality supplements, coupled with advancements in technology and increasing consumer awareness, is set to drive market expansion.

About Future Market Insights (FMI)

Global Carrageenan Gum Market Expected to Reach USD 1.36 Billion by 2032, Growing at a 4.0% CAGR

The global Carrageenan Gum market is anticipated to experience robust growth over the next decade. From an estimated market value of US$ 915.9 Million in 2022, projections indicate a substantial rise to US$ 1,355.7 Million by 2032, driven by a steady CAGR of 4.0% during the forecast period. This promising growth trajectory presents a wealth of opportunities for investors and stakeholders in the industry.

Request Sample Report and Drive Impactful Decisions: https://www.futuremarketinsights.com/reports/sample/rep-gb-2995

Key Highlights of the Carrageenan Gum Market:

The Carrageenan Gum market is set to grow at a CAGR of 4.0% from 2022 to 2032, with the market value expected to increase from US$ 915.9 Million to US$ 1,355.7 Million by 2032.
The European and American markets are among the largest for Carrageenan Gum. In the USA, the market is expected to see a CAGR of 3.90% through 2031, while the European market is projected to grow at a steady rate of 4.4%.
Investors can save up to 30% by customizing reports to focus on specific countries or regions, ensuring targeted insights and efficient resource allocation.

Market Dynamics:

Increasing Demand in Food & Beverage Industry: Carrageenan Gum is widely used as an emulsifier and thickener in various food products, including dairy, meat, and confectionery items. The growing consumer preference for natural and plant-based ingredients is fueling demand.
Expanding Applications in Personal Care & Pharmaceuticals: Carrageenan Gum’s properties make it a valuable ingredient in skincare, hair care, and pharmaceutical products. Its natural emulsifying and water-binding capabilities enhance product textures and efficacy.
Rising Vegan and Plant-Based Trends: The shift towards plant-based diets and veganism is driving demand for Carrageenan Gum as a gelatin alternative in various food products.

Market Opportunities:

Innovations in Extraction and Manufacturing: Advancements in extraction techniques and supply chain improvements are expected to enhance the quality and availability of Carrageenan Gum, boosting market growth.

Increased Applications in Pharmaceuticals: The pharmaceutical industry is exploring Carrageenan Gum for its potential in drug delivery systems and tissue engineering, presenting new avenues for market expansion.

Growth in Personal Care Industry: The personal care sector’s increasing demand for natural ingredients provides significant opportunities for Carrageenan Gum, particularly in skincare and haircare products.

Competitive Landscape:

Leading market players such as CP Kelco ApS, FMC Corporation, Kerry Group, and Cargill, Incorporated are focusing on strategic mergers, acquisitions, and product innovations to strengthen their market positions. For instance:

CP Kelco ApS partnered with Azelis to expand its distribution network globally.
Kerry Group acquired Biosearch Life to enhance its food ingredient sector operations.

Gain Immediate Access to Detailed Market Insights Purchase Now

Regional Insights:

The demand for Carrageenan Gum in the USA is driven by its extensive use in the personal care and pharmaceutical industries. The presence of major cosmetics manufacturers and the rising consumer preference for plant-based ingredients support market growth.
The UK market is poised for growth as consumers increasingly opt for natural ingredient-based foods, boosting demand for Carrageenan Gum.
China’s substantial seafood and meat consumption base, coupled with the growing dairy industry, is expected to drive demand for Carrageenan Gum, supporting market expansion.

About Future Market Insights (FMI)